Cellectar Biosciences, Inc. (NASDAQ:CLRB), announced that an article reporting the efficacy of its proprietary phospholipid ether (PLE) analog agents for the detection, imaging and real-time visualization of colorectal cancer was published in PLOS ONE, an international, peer-reviewed publication. Cellectar is developing a novel drug delivery and retention technology engineered to specifically target and accumulate in malignant tissue. By attaching various agents to this common structure, the company has built a robust pipeline of both diagnostic and therapeutic agents that seek to detect, treat or illuminate cancerous tissue. Cellectar Biosciences, Inc. (NASDAQ:CLRB) belongs to Healthcare sector. Its weekly performance is 23.36%. On last trading day company shares ended up $2.64. Cellectar Biosciences, Inc. (NASDAQ:CLRB) distance from 50-day simple moving average (SMA50) is 6.89%. Oasis Petroleum (NYSE:OAS) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.49. The company had revenue of $368.66 million for the quarter, compared to the consensus estimate of $382.80 million. During the same quarter in the previous year, the company posted $0.80 earnings per share. The company’s revenue for the quarter was up 20.7% on a year-over-year basis. Analysts expect that Oasis Petroleum will post $2.87 EPS for the current fiscal year. Oasis Petroleum Inc. (NYSE:OAS) shares fell -3.01% in last trading session and ended the day at $26.11. OAS Gross Margin is 77.80% and its return on assets is 6.80%. Oasis Petroleum Inc. (NYSE:OAS) quarterly performance is -43.79%. Arcos Dorados Holdings Inc (NYSE:ARCO), McDonald’s largest global franchisee, reported unaudited results for Q3, which included an 11.5 percent decrease in revenues. Also: Systemwide comparable sales increased by 7.4 percent year-over-year. Adjusted EBITDA was $66.1 million, or 26.9% lower year-over-year. The company reported net income of $240,000, compared to net income of $19.6 million in the year-ago period, mainly due to lower operating results and higher foreign exchange losses. "Third quarter results were below our expectations due to continued underlying weakness in the operating environments of our key markets. At the start of the fourth quarter, we are seeing some evidence of stabilizing volume trends and are optimistic that we can benefit from a seasonal pick-up in consumer activity and the promotional campaigns that we have planned through year-end," CEO Woods Staton said in a news release. On 05 November, Arcos Dorados Holding Inc (NYSE:ARCO) shares increased 8.12% and was closed at $6.92. ARCO EPS growth in last 5 year was -12.90%. Arcos Dorados Holding Inc (NYSE:ARCO) year to date (YTD) performance is -41.65%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) on Nov. 5 reported a third-quarter loss of $50.1 million. On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 27 cents. The results topped Wall Street expectations. The average estimate of analysts was for a loss of 30 cents per share. The biopharmaceutical company posted revenue of $14.7 million in the period, which did not meet Street forecasts. Analysts expected $16.7 million, according to Zacks. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)'s stock on 05 November traded at beginning with a price of $5.63 and when day-trade ended the stock finally decreased -3.23% to end at $5.69. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)'s showed weekly performance of -3.07%. MarineMax, Inc. (NYSE:HZO), the nation's largest recreational boat retailer, today announced results for its fourth quarter and fiscal year ended September 30, 2014. Revenue grew 10% to $164.1 million for the quarter ended September 30, 2014 from $149.7 million for the comparable quarter last year. Same-store sales increased approximately 10% on top of a 7% increase for the comparable quarter last year. During the 2014 fourth quarter, the Company recovered $600,000, net of tax and other expenses, from the Deepwater Horizon Settlement Program (Deepwater) for damages it suffered as a result of the Deepwater oil spill in 2010. Also during the 2014 fourth quarter, the Company recognized a gain of $1.0 million, net of tax and other expenses, associated with the sale of a property. During the 2013 fourth quarter, the Company recovered damages of $4.7 million, net of tax and other expenses, from Deepwater. Marinemax Inc. (NYSE:HZO) shares fell -1.35% in last trading session and ended the day at $19.05. HZO Gross Margin is 26.10% and its return on assets is 2.80%. Marinemax Inc. (NYSE:HZO) quarterly performance is 13.60%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
